Publications by authors named "G. Hartung"

Claim this Profile
D
Determinants of left ventricular mass in children with autosomal recessive polycystic kidney disease.
Mathew Lin, Jeremy Rubin, Robert A Palermo, Jarcy Zee, Erum A Hartung

J Nephrol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards clinical magnetic particle imaging: safety measurements of medical implants in a human cadaver model.
Franz Wegner, Thomas Friedrich, Patrick Naoki Elfers, Florian Kleefeldt, Dominik Peter, Viktor Hartung

Commun Eng· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseases.
Muriel Schraad, Mathias Mäurer, Anke Salmen, Tobias Ruck, Timo Uphaus, Hans-Peter Hartung

Ther Adv Neurol Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndrome.
Robin C M Thomma, Susan K Halstead, Laura C de Koning, Eveline J A Wiegers, Dawn S Gourlay, Hans-Peter Hartung

Brain· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A biodegradable polymer plug for liver tract embolization after percutaneous or surgical placement of transhepatic biliary drainage tubes: a feasibility study.
Annette Thurner, Giulia Dalla Torre, Viktor Hartung, Ralph Kickuth

Rofo· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy.
Lars Masanneck, Jan Voth, Noëmi Gmahl, Konstantin Jendretzky, Niklas Huntemann, Hans Peter Hartung

Ann Clin Transl Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria.
Xavier Montalban, Christine Lebrun-Frénay, Jiwon Oh, Georgina Arrambide, Marcello Moccia, Hans-Peter Hartung

Lancet Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The need for epigenotoxicity testing.
Thomas Hartung, Lena Smirnova, Stefan Platz, Ivano Amelio, Marcel Leist

ALTEX· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Responses of Human iPSC-Derived Microglia to Stimulation with Diverse Inflammogens.
Chiara Wolfbeisz, Julian Suess, Nadine Dreser, Heidrun Leisner, Markus Brüll, Thomas Hartung

Cells· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biophysical simulations of fMRI responses using realistic microvascular models: insights into distinct hemodynamics in humans and mice.
Grant Hartung, Avery Berman, Sava Sakadzic, Andreas Linninger, David A Boas

bioRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ex-vivo Comparative Study on the Morcellation Efficiency of Different Morcellators].
Benedikt Becker, Christopher Netsch, Andreas J Gross, Clemens Rosenbaum, Friedrich Otto Hartung

Aktuelle Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials.
Jeffrey A Cohen, Douglas L Arnold, John DeLuca, Hans-Peter Hartung, Ludwig Kappos

Mult Scler· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathology-oriented multiplexing enables integrative disease mapping.
Malte Kuehl, Yusuke Okabayashi, Milagros N Wong, Lukas Gernhold, Gabriele Gut, Michael Hartung

Nature· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A circuitous route to the diagnosis of a very rare disease].
C Glück, G Waertel, L Schminke, C Brossmann, M Lehringer-Polzin, W Hartung

Inn Med (Heidelb)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of alcohol intoxication on primary and secondary haemostasis - results from comprehensive coagulation testing.
Ronja Sabine Schmölders, Till Hoffmann, Derik Hermsen, Michael Bernhard, Fritz Boege, Benno Hartung

Int J Legal Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From cellular perturbation to probabilistic risk assessments.
Alexandra Maertens, Breanne Kincaid, Eric Bridgeford, Celine Brochot, Arthur de Carvalho E Silva, Thomas Hartung

ALTEX· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De-escalating and discontinuing disease-modifying therapies in multiple sclerosis.
Géraldine Androdias, Jan D Lünemann, Elisabeth Maillart, Maria Pia Amato, Bertrand Audoin, Hans-Peter Hartung

Brain· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prodromal individuals' perspective on active recruitment for early detection of α-synucleinopathies.
Sinah Röttgen, Eva Schaeffer, Annette Rogge, Ramona Hartung, Konstantin Kufer

NPJ Parkinsons Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of microglia in multiple sclerosis: implications for treatment with Bruton's tyrosine kinase inhibitors.
Patrick Vermersch, Laura Airas, Thomas Berger, Florian Deisenhammer, Nikolaos Grigoriadis, Hans-Peter Hartung

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping out strategies to further develop human-relevant, new approach methodology (NAM)-based developmental neurotoxicity (DNT) testing.
Eike Cöllen, Kristina Bartmann, Jonathan Blum, Kelly Carstens, Ivana Celardo, Thomas Hartung

ALTEX· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis.
Alice G Willison, Ramona Hagler, Margit Weise, Saskia Elben, Niklas Huntemann, Hans-Peter Hartung

Cells· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different Treatment Outcomes of Multiple Sclerosis Patients Receiving Ocrelizumab or Ofatumumab.
Sven G Meuth, Stephanie Wolff, Anna Mück, Alice Willison, Konstanze Kleinschnitz, Hans-Peter Hartung

Ann Neurol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology: A Review.
Fatme Seval Ismail, Marco Gallus, Sven G Meuth, Hideho Okada, Hans-Peter Hartung

JAMA Neurol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of plant density and duration of vegetative growth phase on agronomic traits of medicinal cannabis (Cannabis sativa L.): A regression analysis.
Torsten Schober, Achim Präger, Jens Hartung, Simone Graeff-Hönninger

PLoS One· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label Trial.
Hans-Peter Hartung, Ralph H B Benedict, Thomas Berger, Robert A Bermel, Bruno Brochet

Neurology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis